News
The clinical hold is due to questions about BX004’s nebulizer device, temporarily pausing US enrollment in the cystic ...
The regulatory body determined that PTC Therapeutics’ New Drug Application for vatiquinone did not provide sufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback